.

 

Leaflet 2020: EMOST-MED-2020 ENG (PDF, 5 MB)

.

What is the profile of the company?

– developing and manufacturing the EMOST Redox 1.1 health-care, or medical device
– service of this EMOST device only, and sales of this device only
– 7/7 Customer service, operation (close to 120 Health Centers in Europe)

.

How long has the firm been in operation?

For 17 years, experience of service are 17 years, scientific researches since 19 years, certification (EU) of Medical Device in 2011-2014.

.

Advantage

Several years of operational routine, the device: personal production, high-tech and easy-to use, 14 different sessions (medical therapies or wellness sessions), natural based procedure, selling directly, favourable price in treatments and in device investment, currently unique medical method at some problematic neurological illnesses.

.

Market position

The EMOST Redox 1.1 typ. device is a health-care, or medical device and therapy which was registered in the history book of medical science in 2010 after 11 years of research work and 17 years of normal operational application in franchise system. The former version of the device, not certified yet as medical device contributed to the recovery of 145,000 persons in 57 cities of Hungary using 107 pcs of devices (in health-care category). The Product from its better position as a new, certified medical device intends to achieve the same degree of prevalence typically in Western-Europe and in the USA as it has reached in Hungary.

Our company has many years of satisfied clients of the need for advertising, serving more careful listening. Seven years ago, excellent professionals, academic work, service experience, continuing education and quality is achieved by means of the name BioLabor company and its EMOST – ElectroMagnetic Own Signal Therapy natural means and skills, and at the same time.

.

Professional market – The Neurology

The new procedure covers nearly 27% of illnesses, its special field of application is neurology, the affected population in Europe is 164 million persons, 79 million in the USA (see Annex), in order to meet the 2,3% market share potential, the 8 million EUR (*worst-case 5,8 million EUR) corrected revenue of the 3-year business plan 44,000 persons will be sufficient in 2013, 110,000 persons in 2014 and 200,000 persons in 2015, which means that the real potential is hardly exploited.

Datas: The affected population in Europe is 164 million persons, 79 million in the USA (see Annex): panic attacks (rate of populations is 2.5%), anxiety (8.5%), depression (2.6%), sleeping disorders (6.7%), stroke-risk (6.9%), cardiological risk (11.7%), arhythmia (4,1%), digestive diseases (8.9%), allergy (4.2%), burn-out (11%), alcohol dem. (8%), PTSD (6,7%).

How does this resolve a particular sector’s problem?
– safe method of sensitive intervention in the case of nervous system based diseases
– rapid and save procedure
– does not cause personality disorder
– no side effects* (extremely low risks only)

.

The Company

Our (originates hungarian) company has got several years’ professional experience and also a kind of conservative approach to life. We have gathered skilled colleagues to organize a team in which people can not only look after the patients but are sufficiently open to cutting-edge technologies as well. Our staff and company proprietors work in different areas of healthcare and are outstanding representatives of general practitioners, internists, surgeons, military doctors, natural therapeutics, pharmacists, haematologists, university teachers, scientists, and every colleague has been using our own-produced technology with success in their daily routine for years. The Company attends many national and international congresses and conferences every year. Recently we took part in the 8th European Biophysics Congress (nominated research team), and International Conference of Preventive Medicine and Public Health, International Conference of Preventive Medicine and Public Health at Pécs, Hungary, National Family Doctors Congress Romania, and Neurology Congress at Ukrainian National Science Academy, Research Partneship of  the Russian Academy of Medical Sciences Medical Radiological Research Center (Obninsk, Moscow), development and testing of new preventive and therapeutic protocolls, such as somatic gene and cell therapies (in particular stem cell therapies on neurological and neuromuscular disorders) and immunotherapies.

.

R&D

The main aim of the Humans is to perform the process of self-recovery, meaning that your body is able to heal itself. I think we got very close to it. After more than a decade of research we can say that humans are able to recover control of their own state, similarly, when we are tired from working hard and go to bed at night and we wake up fresh in the morning. How does it happens? We deal with this process.

 .

Target groups of EMOST

a) 45-55 age group belonging to ABCD income category, mainly intellectual, medium level managers, primarily women (65%)
b) medium level and senior managers, sales managers of companies (contrentation level, stress managing, develop of IQ, creativity, burn-out etc.)
c) units, corps of law enforcement organizations (police, military forces, sentence enforcement organs, special operational units /SWAT, prison guard, armed forces (psychic stability under anf after the mission, anxiety, PTSD ), S.W.A.T. units (tension managing, concentration etc.)
d) leading sportsmen, professional sportsmen, key sport clubs (vital capacity, stress managing, menstruations period, regeneration etc.)
e) recreational SPA hotels/sanatoria, rehabilitation clinics and private practice (real wellness deal, optimal milieu etc.)
f) preventive wiev, and depedency-free clubs or organisations
g) clinics for children (evolution, development, behavior, capability of health, stress, epilepsy, stutter, nightmare, incontinence etc.)

.

Advantages of the current method

– alternative procedure to neurological based diseases
– chemical agent-free, depedency-free, convenient
– rapid procedure
– may be provided as a course (4-5 treatments, repeated 2-3 years)
– effects on hormones and regulators
– develops genetic- and biological intelligence

.

Benefits of procedure

The Own Signal Therapy helps to adjust and regulate directly the basic physiological flows, bio electrochemical synchronisation, event-event communications, potentials- action potentials changing, helps efficiency of organs and cells, in signal transmission and signal recognising (hormones), by doing that it helps the homeostasis to recover itself, and helps to recover in problematic cases.

Furthermore, the EM-Own Signal Therapy is non-invasive, no chemical input, its principle is the body’s non-defence mechanism, doesn’t use any artificial electric- and electromagnetic signals under sessions, this natural based signal can guarantee extreme low risks, because it works under the natural range of the body. It also improves efficiency by better coherence.

.

We could effectively treat diseases such as:

anxiety, fear, panic attacks, inhibition, psychic stress related (mental) diseases, epilepsy, depression, lethargy, burn-out, stress-related allergie, sleep disorders, cardiovascular diseases, arrhythmia, asthma bronchial, chronic shortness of breath, phantom limb pain and amputee rehabilitation, rehabilitation of Post-Traumatic Stress Diseases, allowance of risks in implantation, chronic stomach cramps, irritable intestine syndrome, cognitive difficulties, bulimia, chronic constipation, incontinency, potency, conception difficulties, Happy Coctail™, Maxi Vital™, and Olympic™ sessions.

 .

The main benefit and other benefits of the EMOST™ technology

– the main benefit: easy-to-use
– cost-effective way
– relatively long-term results (course is enough in 2-3 years)
– low number of treatments needed (one specific course is about 4-5 treatments, treatment is weekly)
– no addiction, no defensive reactions in healing

.

Strategic partnerships

Hungarian National Institute for Medical Rehabilitation, Hungarian Army Independent Health Insurance, Independent Armed Forces Trades Union Congress, Hungarian Independent Police Union, National Police and Armed Forces Training Center, Hungarian Civil Servants Union, Union of Hungarian HR’s, National Athletic Association, Golden Hearth Fundation of Cardial Health, Some National and Privat Clinics of Children (charity), Some National Public Clinics and Rehabilitations Centers, International Tisza Cluster Association (ITCA), European Union Donau Strategy, Ukrainian Transcarpatian Develop Office (Zakarpatya), some discretious contract with politics, some discretious contract with manager training centers, Committee of Research- and Methology of Hungarian Society of Sport Science (MSTT), Medical Radiology Research Institute of Russian Federation, Obninsk, Russia, and HQ of International Bodyguard and Security Services Association (IBSSA), Sovereign Order of Saint John of Jerusalem, Knights of Malta, Federation of the Autonomous Priories (KMFAP) and UNICEF.

.

.

.

.

.

.

.

Charity

In 2010 on the premises of the floods in Felsőzsolca (Hungary) we administered emergency treatments in order to protect the members of the rescue team and the civil citizens. The results of our treatments of stress, panic, and immune system of those involved were greatly acknowledged even by healthcare professionals.

The treatments are half-price or free of charge for children, and free-of-charge in humanitarian service, and cathastrophic situations (since 2005 -in Hungary and in our international professional network).

.

Outstanding scientific achievement

According to preliminary, professionally competent opinions the EMOST™ method/device may be suitable for the continuous protection of the health and mental condition of the astronauts during the 32 months First Human Mars Exploration envisaged for 2028-2032. The Russian-Hungarian (-American) analysis began in December 2012.

.

We appreciate your enquiry!
With friendly regards,

Attila ERDŐFI-SZABÓ Ph.D., MD.Sci.